TBPH
Theravance Biopharma Inc
17.00$
+0.0%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -15.8% | -4.9% | -7.0% | -31.0% | -30.8% | -4.8% | 279.7% | 794.3% | -32.6% | -13.2% | 414.0% | -42.8% | 49.7% | |
| 6.0% | 8.1% | 8.1% | 6.9% | 4.5% | 3.7% | 6.8% | 3.5% | 3.2% | 0.9% | 4.7% | 9.9% | 3.8% | |
| 39.9% | 33.2% | 36.1% | 37.7% | 29.4% | 31.1% | 31.7% | 17.3% | 22.9% | 9.8% | 25.4% | 28.9% | 18.7% | |
| -8.6% | -19.4% | 28.4% | 18.9% | -2.0% | 74.0% | 337.5% | 602.4% | -84.4% | 570.2% | 428.4% | -375.0% | 232.8% | |
| 0.1% | 3.9% | 0.6% | 0.3% | 0.1% | 1.0% | 0.0% | 0.1% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | |
| -0.1% | -3.9% | 117.4% | -21.3% | -103.1% | 83.6% | 199.1% | -138.4% | -501.5% | 1.3% | 297.2% | -291.4% | -103.0% | |
| -200.1% | -175.2% | -11.8% | -3.2% | -2.4% | -2.8% | -5.7% | -1.9% | -3.4% | -4.3% | -32.9% | 28.1% | -2.5% | |
| -200.1% | -174.3% | -11.8% | -0.3% | -2.2% | -1.9% | -5.5% | -1.9% | -2.0% | -3.2% | -31.5% | 22.2% | -2.7% | |
| -216.1% | -183.0% | 98.5% | -52.5% | -136.2% | 76.9% | 473.2% | 654.0% | -536.0% | -15.2% | 679.7% | -312.0% | -56.1% | |
| -16.0% | -8.7% | -7.7% | -31.2% | -30.9% | -5.8% | 279.7% | 794.2% | -32.6% | -13.2% | 414.0% | -42.8% | 49.7% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.